Trial on a Strategy Combining Rapid Diagnostic Testing and Antimicrobial Stewardship to Improve Antibiotic Use in Patients with Hospital-acquired Pneumonia.

NACompletedINTERVENTIONAL
Enrollment

116

Participants

Timeline

Start Date

February 21, 2020

Primary Completion Date

August 31, 2023

Study Completion Date

August 31, 2023

Conditions
Hospital-acquired Pneumonia
Interventions
DIAGNOSTIC_TEST

Rapid Diagnostic Testing

Automated microbiological diagnostic device based on multiplex PCR analysis, allowing detection of multiple pathogens and resistance markers in one hour from invasive and non-invasive respiratory samples

DIAGNOSTIC_TEST

Antimicrobial stewardship

After clinical examination, routine biological tests will be performed. This includes blood culture, direct examination and culture of invasive or noninvasive respiratory samples, urinary antigen tests for Legionella and Pneumococcus, Influenza PCR on nasopharyngeal swabs (during the influenza season).

Trial Locations (8)

54511

CHRU Nancy, Nancy

75006

Hôpitaux Universitaires Paris Centre (Cochin) - service Médecine Intensive - Réanimation, Paris

75014

Groupe Hospitalier Paris Saint Joseph, Paris

Hôpitaux Universitaires Paris Centre-Site Cochin, Paris

75018

Hôpitaux Universitaires Paris Nord Val de Seine-Site Bichat (SMIT), Paris

94010

Hôpitaux Universitaires Henri Mondor, Créteil

Unknown

Hôpitaux Universitaires Paris Nord Val de Seine - EPRI (Bichat), Paris

Hôpitaux Universitaires Paris Nord Val de Seine - MIR (Bichat), Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT04153682 - Trial on a Strategy Combining Rapid Diagnostic Testing and Antimicrobial Stewardship to Improve Antibiotic Use in Patients with Hospital-acquired Pneumonia. | Biotech Hunter | Biotech Hunter